Literature DB >> 29579888

Severe Scedosporium apiospermum Infection in a Recent Renal Transplant Recipient: Case Report.

M J Torres-Sánchez1, E Hernández-García2, J Gómez-Sánchez3, M Palomares-Bayo2, M Peña-Ortega2, P Galindo-Sacristán2, C De Gracia-Guindo2, A Osuna-Ortega2.   

Abstract

Infections in transplanted patients are still an important cause of morbidity and mortality. Among them, fungal infections with pathogens have become increasingly more prevalent in the last decade. We report the clinical course and management of disseminated Scedosporium apiospermum infection in a kidney transplant recipient, with microbiological isolation of the fungus in cerebrospinal fluid culture. S apiospermum is a fungus that is distributed worldwide and can be grown from soil samples or stagnant water. Disseminated infection is the most frequent form of infection, with cerebral involvement in most cases, which leads to a very high mortality (around 75%). Post-transplant renal infections require a thorough evaluation. Specifically, a high suspicion index is necessary, considering Scedosporium infection among the differential diagnosis of invasive fungal diseases in renal transplantation patients. It is essential to confirm the microbiological diagnosis for an adequate diagnosis and treatment.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29579888     DOI: 10.1016/j.transproceed.2017.09.051

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  The Synergistic Effect of Tacrolimus (FK506) or Everolimus and Azoles Against Scedosporium and Lomentospora Species In Vivo and In Vitro.

Authors:  Zikuo Wang; Mei Liu; Luyao Liu; Linyun Li; Lihua Tan; Yi Sun
Journal:  Front Cell Infect Microbiol       Date:  2022-04-14       Impact factor: 6.073

2.  Subcutaneous phaeohyphomycosis caused by Hongkongmyces snookiorum in a kidney transplant patient: a case report.

Authors:  Deng Linqiang; Chen Yiguo; Xu Heping; Chen Dongke; Hu Longhua; Gui Xiaomei; Zou Xia
Journal:  BMC Infect Dis       Date:  2020-08-01       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.